Smartleaf Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Buy
20,414
+3,128
+18% +$438K 0.1% 180
2025
Q4
$2.13M Buy
17,286
+3,623
+27% +$440K 0.08% 218
2025
Q3
$1.54M Buy
13,663
+4,937
+57% +$561K 0.1% 236
2025
Q2
$966K Sell
8,726
-2,093
-19% -$223K 0.09% 260
2025
Q1
$1.21M Buy
10,819
+958
+10% +$98.9K 0.12% 194
2024
Q4
$907K Buy
9,861
+3,572
+57% +$322K 0.09% 233
2024
Q3
$526K Buy
6,289
+3,320
+112% +$253K 0.06% 298
2024
Q2
$204K Buy
2,969
+495
+20% +$33K 0.03% 375
2024
Q1
$181K Buy
2,474
+1,614
+188% +$124K 0.03% 386
2023
Q4
$67.5K Buy
+860
New +$66.9K 0.02% 491

Other funds holding GILD

Smartleaf Asset Management's GILD Position: Q1 2026 in Review

Smartleaf Asset Management increased its Gilead Sciences (GILD) stake by 18% in Q1 2026, buying an estimated $438K and bringing the position to 20,414 shares worth $2.78M. The position accounts for 0.1% of the portfolio, ranked #180.

Smartleaf Asset Management first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Smartleaf Asset Management held 20,414 shares of Gilead Sciences worth $2.78M as of Q1 2026.
  • Smartleaf Asset Management bought 3,128 Gilead Sciences shares in Q1 2026, an estimated $438K.
  • Gilead Sciences made up 0.1% of Smartleaf Asset Management's portfolio in Q1 2026, its #180 holding.
  • Smartleaf Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.